Publications
2 results found
Bertrand JA, Woodward DF, Sherwood JM, et al., 2021, The role of EP<sub>2</sub> receptors in mediating the ultra-long-lasting intraocular pressure reduction by JV-GL1, BRITISH JOURNAL OF OPHTHALMOLOGY, Vol: 105, Pages: 1610-1616, ISSN: 0007-1161
- Author Web Link
- Cite
- Citations: 3
Bertrand JA, Woodward DF, Sherwood JM, et al., 2021, Deletion of the gene encoding prostamide/prostaglandin F synthase reveals an important role in regulating intraocular pressure, Prostaglandins, Leukotrienes and Essential Fatty Acids, Vol: 165, Pages: 102235-102235, ISSN: 0952-3278
Prostamide/prostaglandin F synthase (PM/PGFS) is an enzyme with very narrow substrate specificity and is dedicated to the biosynthesis of prostamide F2α and prostaglandin F2α (PGF2α.). The importance of this enzyme, relative to the aldo-keto reductase (AKR) series, in providing functional tissue prostamide F2α levels was determined by creating a line of PM/PGFS gene deleted mice. Deletion of the gene encoding PM/PGFS (Fam213b / Prxl2b) was accomplished by a two exon disruption. Prostamide F2α levels in wild type (WT) and PM/PGFS knock-out (KO) mice were determined by LC/MS/MS. Deletion of Fam213b (Prxl2b) had no observed effect on behavior, appetite, or fertility. In contrast, tonometrically measured intraocular pressure was significantly elevated by approximately 4 mmHg in PM/PGFS KO mice compared to littermate WT mice. Outflow facility was measured in enucleated mouse eyes using the iPerfusion system. No effect on pressure dependent outflow facility occurred, which is consistent with the effects of prostamide F2α and PGF2α increasing outflow through the unconventional pathway. The elevation of intraocular pressure caused by deletion of the gene encoding the PM/PGFS enzyme likely results from a diversion of the endoperoxide precursor pathway to provide increased levels of those prostanoids known to raise intraocular pressure, namely prostaglandin D2 (PGD2) and thromboxane A2 (TxA2). It follows that PM/PGFS may serve an important regulatory role in the eye by providing PGF2α and prostamide F2α to constrain the influence of those prostanoids that raise intraocular pressure.
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.